Funder
DAAD
Horizon 2020 Framework Programme
CONICET
Universidad Nacional de Rosario
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference59 articles.
1. Coppack S, Lant A, McIntosh C, Rodgers A. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non- insulin dependent diabetes mellitus. Br J Clin Pharmacol. 1990;29:673–84. https://doi.org/10.1111/j.1365-2125.1990.tb03688.x.
2. Lebovitz HE. Oral antidiabetic agents: 2004. Med Clin North Am. 2004;88:847–63. https://doi.org/10.1016/j.mcna.2004.05.002.
3. Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, et al. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res. 2002;19:921–5. https://doi.org/10.1023/a:1016473601633.
4. Karttunen P, Uusitupa M, Nykänen S, Robinson JD, Sipilä J. The pharmacokinetics of glibenclamide: a single dose comparison of four preparations in human volunteers. Int J Clin Pharmacol Ther Toxicol. 1985;23:642–6.
5. Neugebauer G, Betzien G, Hrstka V, Kaufmann B, von Möllendorff E, Abshagen U. Absolute bioavailability and bioequivalence of glibenclamide (semi-Euglucon N). Int J Clin Pharmacol Ther Toxicol. 1985;23:453–60.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献